Bisoprolol Fumarate And Hydrochlorothiazide recalls
Bisoprolol Fumarate And Hydrochlorothiazide products have been recalled 2 times, most recently on 11 Feb 2026. The recalling company is usually Unichem Pharmaceuticals USA. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2021
Last 12 months1reported
Class I00% of total
Ongoing1latest 11 Feb 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why bisoprolol fumarate and hydrochlorothiazide is recalled
Companies
Product types
By year
Ongoing bisoprolol fumarate and hydrochlorothiazide recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bisoprolol Fumarate and Hydrochlorothiazide tablets recalledBisoprolol Fumarate And Hydrochlorothiazide | Unichem Pharmaceuticals USA | Nitrosamine Impurity | Nationwide |
All bisoprolol fumarate and hydrochlorothiazide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bisoprolol Fumarate and Hydrochlorothiazide tablets recalledBisoprolol Fumarate And Hydrochlorothiazide | Unichem Pharmaceuticals USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Bisoprolol Fumarate And Hydrochlorothiazide Tablets 2.5 mg/6.25 mg recalledBisoprolol Fumarate And Hydrochlorothiazide | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.